Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current landscape of sequencing ADCs in metastatic breast cancer.
McLaughlin S, Ravani LV, Moy B, Medford AJ, Isakoff SJ, Liu T, Ellisen LW, Spring LM, Wander SA, Abelman RO. McLaughlin S, et al. Among authors: spring lm. Ther Adv Med Oncol. 2025 Dec 17;17:17588359251396656. doi: 10.1177/17588359251396656. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 41424607 Free PMC article. Review.
Understanding first-line treatment patterns and survival outcomes across sociodemographic groups of women with metastatic triple-negative breast cancer in the United States: a real-world study.
Tolaney SM, Spring L, Abdou YG, Rehnquist MK, Hogea C, Estrin A, Sjekloca N, Lai C, Kalinsky K. Tolaney SM, et al. Among authors: spring l. ESMO Open. 2025 Oct;10(10):105841. doi: 10.1016/j.esmoop.2025.105841. Epub 2025 Oct 7. ESMO Open. 2025. PMID: 41061347 Free PMC article.
Selection biases in the systematic collection of breast biobank specimens.
Bar Y, Wang GX, Gioia GE, Fell G, Chou SS, Bossuyt V, Isakoff SJ, Moy B, Ellisen LW, Lehman CD, Spring LM. Bar Y, et al. Among authors: spring lm. NPJ Breast Cancer. 2025 Aug 1;11(1):83. doi: 10.1038/s41523-025-00798-9. NPJ Breast Cancer. 2025. PMID: 40750597 Free PMC article.
Effectiveness of sacituzumab govitecan and management of neutropenia in patients with metastatic triple-negative breast cancer treated in real-world settings in the United States.
Nanda R, Yam C, Spring L, Bhave MA, Ntalla I, Valdez T, Stwalley B, Liang C, Wu WH, Sjekloca N, Sadetsky N, Lai C, Kalinsky K. Nanda R, et al. Among authors: spring l. ESMO Open. 2025 Jun;10(6):105308. doi: 10.1016/j.esmoop.2025.105308. Epub 2025 Jun 5. ESMO Open. 2025. PMID: 40479864 Free PMC article.
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.
Medford AJ, Velimirovic M, Gefen Y, Niemierko A, Gerratana L, Davis AA, Clifton K, Keenan J, Podany E, Hensing WL, Reduzzi C, Dai CS, Kiedrowski LA, Spring LM, Ellisen LW, Doebele RC, Cristofanilli M, Getz G, Bardia A. Medford AJ, et al. Among authors: spring lm. Breast Cancer Res Treat. 2025 Aug;212(3):437-447. doi: 10.1007/s10549-025-07710-w. Epub 2025 May 29. Breast Cancer Res Treat. 2025. PMID: 40439821 Free PMC article.
Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2- breast cancer: a randomized phase 3 trial.
Cardoso F, O'Shaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, Harbeck N, Telli ML, Cescon DW, Fasching PA, Shao Z, Loirat D, Park YH, Fernandez MG, Rubovszky G, Spring L, Im SA, Hui R, Takano T, André F, Yasojima H, Ding Y, Jia L, Karantza V, Tryfonidis K, Bardia A. Cardoso F, et al. Among authors: spring l. Nat Med. 2025 Feb;31(2):442-448. doi: 10.1038/s41591-024-03415-7. Epub 2025 Jan 21. Nat Med. 2025. PMID: 39838117 Free PMC article. Clinical Trial.
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).
Spring LM, Scarpetti L, Medford AJ, Niemierko A, Comander A, Mulvey T, Schnipper L, Isakoff SJ, Moy B, Wander SA, Shin J, Ephrem Z, Laposta AR, Denault E, Abraham E, Calistro G, Kalashnikova E, Rodriguez A, Liu MC, Aleshin A, Peppercorn J, Ellisen LW, Bardia A. Spring LM, et al. NPJ Breast Cancer. 2025 Jan 7;11(1):2. doi: 10.1038/s41523-024-00708-5. NPJ Breast Cancer. 2025. PMID: 39774684 Free PMC article.
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.
Abelman RO, Wu B, Barnes H, Medford A, Norden B, Putur A, Bitman E, Thant W, Liu T, Weipert C, Fell G, Spring LM, Wander SA, Moy B, Vidula N, Isakoff SJ, Varkaris A, Juric D, Corcoran RB, Ellisen LW, Bardia A. Abelman RO, et al. Among authors: spring lm. Clin Cancer Res. 2025 May 15;31(10):1966-1974. doi: 10.1158/1078-0432.CCR-24-2771. Clin Cancer Res. 2025. PMID: 39745368 Free PMC article.
132 results